Underrecognized diagnostic discordance and delay in endometrial dedifferentiated and undifferentiated carcinoma
Journal of Obstetrics and Gynaecology Research · 2025-03 · 51 (3)
DOI: 10.1111/jog.16260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 06.03.2025. Verfasst von Saria Kawano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Carcinoma, Endometrioid, Delayed Diagnosis, Carcinoma. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Aim
Dedifferentiated and undifferentiated endometrial carcinoma (DC/UC) is a rare subtype of endometrial cancer characterized by undifferentiated carcinoma components. This study aimed to investigate diagnostic discrepancies and delays in DC/UC and compare them with low‐grade endometrioid carcinoma (LGEC).
Methods
We retrospectively analyzed 20 DC/UC and 40 LGEC cases finally diagnosed at our hospital (2016–2024). We compared the data of the two groups, including clinicopathologic characteristics and diagnostic intervals defined as the time from the date of initial biopsy to the date of definitive diagnosis. We assessed diagnostic discordances between preoperative diagnoses, including radiological, clinical, and biopsy, and final diagnoses with immunohistochemical analyses.
Results
DC/UC cases exhibited significantly longer diagnostic intervals (median 46 vs. 5 days, p = 0.037) and required more biopsy attempts (median two vs. 1, p = 0.002) and immunohistochemical tests (median 19 vs. 6, p = 0.001) than LGEC cases. In preoperative diagnoses, 60% of DC/UC cases showed diagnostic discrepancies. Radiological findings frequently suggested uterine sarcoma in DC/UC (30%, 6/20). Only 50% of DC/UC were suggested via initial biopsy. Immunohistochemistry revealed mismatch repair deficiency in 70% of DC/UC cases.
Conclusions
Frequent diagnostic discrepancies and delays were observed in DC/UC, possibly due to its atypical imaging and histopathological features. Raising awareness of DC/UC's clinical and pathological characteristics is crucial to minimizing diagnostic delays. Given its frequency (at least 1% of endometrial cancers) and eligibility for emerging therapies, prioritizing DC/UC in differential diagnoses and improving diagnostic workflows through interdisciplinary collaboration are required for timely and effective treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Hiroshi Yoshida
Zitieren
APA
Kawano, S., Yoshida, H., Kikkawa, N., Kobayashi-Kato, M., Tanase, Y., Uno, M., & Ishikawa, M. (2025). Underrecognized diagnostic discordance and delay in endometrial dedifferentiated and undifferentiated carcinoma. Journal of Obstetrics and Gynaecology Research, 51(3). https://doi.org/10.1111/jog.16260
Vancouver
Kawano S, Yoshida H, Kikkawa N, Kobayashi-Kato M, Tanase Y, Uno M, et al. Underrecognized diagnostic discordance and delay in endometrial dedifferentiated and undifferentiated carcinoma. Journal of Obstetrics and Gynaecology Research. 2025;51(3). doi:10.1111/jog.16260
BibTeX
@article{Kawano2025,
author = {Kawano, Saria and Yoshida, Hiroshi and Kikkawa, Nao and Kobayashi-Kato, Mayumi and Tanase, Yasuhito and Uno, Masaya and Ishikawa, Mitsuya},
title = {Underrecognized diagnostic discordance and delay in endometrial dedifferentiated and undifferentiated carcinoma},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
volume = {51},
number = {3},
doi = {10.1111/jog.16260}
}
EUVIMED